TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.

Clinical trial NCT06602323 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06602323
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Acute Myeloid Leukemia

Start date: 2024-10-01
Primary completion: 2028-10-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.